Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML)
Wednesday, May 04, 2022Agastiya Biotech and Vopec Pharmaceuticals announce that the US FDA has granted Orphan Drug Designations for Pancreatic Cancer and AML for its novel small molecule AB AB is a small molecule PDL checkpoint inhibitor that also targets aberrant intrac...
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar
Tuesday, May 03, 2022Endo International plc announced today that its subsidiary Endo Ventures Limited EVL acquired six developmentstage readytouse injectable product candidates from Nevakar Injectables Inc a subsidiary of Nevakar Inc These six product candidates that wou...
Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing
Tuesday, May 03, 2022Nicoya Lifesciences a global innovator of digital proteomics solutions for diagnostics and biotherapeutic discovery today announced the acquisition of LSK Technologies a University of Toronto startup decentralizing laboratory testing with their hight...
Inmagene Receives FDA's IND Clearance for OX40 Antagonist
Monday, May 02, 2022Inmagene Biopharmaceuticals announces that the US Food and Drug Administration FDA has cleared drug candidate IMG a monoclonal antibody against OX to proceed to Phase I clinical development Inmagene is developing IMG in partnership with HUTCHMED Chin...
GC Biopharma Concludes Agreement With Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Friday, April 29, 2022GC Biopharma and Acuitas Therapeutics a company focused on developing lipid nanoparticle LNP delivery systems to enable messenger RNA mRNAbased therapeutics today announced that they have entered into a Development and Option agreement for Acuitas LN...
Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
Friday, April 29, 2022Plexium Inc Plexium and AbbVie have entered into an exclusive strategic collaboration to develop and commercialize novel Targeted Protein Degradation TPD therapeutics for neurological conditions This collaboration combines AbbVies extensive neuroscie...
Serenity Bioworks Acquires DC-TAB for Lupus Nephritis
Thursday, April 28, 2022Serenity Bioworks announces today it has completed the acquisition of DCTAB a recombinant human HspB that was previously in clinical development for relapseremitting multiple sclerosis Included in the transaction are the manufacturing material toxico...
Virpax Successfully Completes Initial Preclinical Studies for VRP324
Thursday, April 28, 2022Virpax Pharmaceuticals Inc a company specializing in developing nonaddictive product candidates for pain management CNS disorders and antiviral indications reported preclinical pharmacokinetics PK results for VRP METCBD a nosetobrain delivery platfor...
Castle Biosciences Completes Acquisition of AltheaDx
Wednesday, April 27, 2022Castle Biosciences Inc a company improving health through innovative tests that guide patient care today announced that it has completed its acquisition of AltheaDx Inc AltheaDx AltheaDx is a commercialstage molecular diagnostics company specializing...
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity
Wednesday, April 27, 2022RVAC Medicines Pte Ltd RVAC an emerging messenger RNA mRNA platform company incubated in Singapore by CBC Group CBC today announced the completion of its series B financing bringing the companys total funds raised since its inception in June to US m...
